Burcon Nutrascience Corporation
BU.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -78.38% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -78.38% | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -163.76% | -- | -- | -- |
| SG&A Expenses | -1.05% | 13.97% | 28.61% | 18.74% | -8.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.10% | 28.89% | 10.73% | 6.02% | -2.60% |
| Operating Income | 8.24% | -41.84% | 2.38% | -6.02% | -6.20% |
| Income Before Tax | 14.64% | -61.55% | 4.02% | -14.08% | 87.57% |
| Income Tax Expenses | -- | -- | -- | -36.08% | -- |
| Earnings from Continuing Operations | 14.64% | -61.55% | 4.02% | -13.39% | 87.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.64% | -61.55% | 4.02% | -13.39% | 87.57% |
| EBIT | 8.24% | -41.84% | 2.38% | -6.02% | -6.20% |
| EBITDA | 9.52% | -42.40% | 3.07% | -3.90% | -7.04% |
| EPS Basic | 27.64% | -37.50% | 21.95% | 1.61% | 88.87% |
| Normalized Basic EPS | 27.27% | -38.18% | 22.08% | -168.57% | 78.13% |
| EPS Diluted | 27.64% | -37.50% | 21.95% | 1.61% | 88.87% |
| Normalized Diluted EPS | 27.27% | -38.18% | 22.08% | -168.57% | 78.13% |
| Average Basic Shares Outstanding | 17.21% | 16.85% | 22.50% | 16.07% | 11.92% |
| Average Diluted Shares Outstanding | 17.21% | 16.85% | 22.50% | 16.07% | 11.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
